OCUL
$6.65+5.72%
Ocular Therapeutix Inc.Stock · HealthcareRussell 2000 · 0.06% of IWMNasdaq Composite · 0.006% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.002% of IWV
OCUL financial statements
The full income statement, balance sheet, and cash-flow statement for Ocular Therapeutix Inc. (OCUL), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 155.9M2024-09 157.2M2024-12 159.0M2025-03 159.3M2025-06 174.0M2025-09 213.0M2025-12 217.7M2026-03 219.0M2026-06 219.6M+40.9% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 52.0M-18.5% | 63.7M+9.0% | 58.4M+13.5% | 51.5M+18.3% | 43.5M+150.1% | |
| Cost of revenue | 6.57M+16.9% | 5.63M+6.5% | 5.28M+16.3% | 4.54M+3.0% | 4.41M+111.5% | |
| Research & development | 197M+54.4% | 128M+109.0% | 61.1M+14.2% | 53.5M+6.7% | 50.1M+74.5% | |
| Selling, general & administrative | 64.4M+6.1% | 60.7M+78.7% | 33.9M+5.3% | 32.2M+1.1% | 31.9M+39.5% | |
| General & administrative | 64.4M+6.1% | 60.7M+78.7% | 33.9M+5.3% | 32.2M+1.1% | 31.9M+39.5% | |
| Selling & marketing | 53.9M+29.7% | 41.6M+2.6% | 40.5M+1.6% | 39.9M+13.4% | 35.2M+32.2% | |
| Operating income | -270M-57.2% | -172M-108.5% | -82.4M-4.7% | -78.7M-0.8% | -78.0M-24.2% | |
| Interest expense | 11.8M-12.8% | 13.6M+19.7% | 11.3M+61.5% | 7.02M+5.3% | 6.67M-1.4% | |
| Other non-operating income | 4.08M+118.8% | -21.7M-2172400.0% | -1.00K+0.0% | -1.00K-100.0% | 71.5M+177.0% | |
| Income tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -266M-37.4% | -194M-139.7% | -80.7M-13.7% | -71.0M-984.1% | -6.55M+95.8% | ||
| Net income to common | — | — | -80.7M-13.7% | -71.0M-984.1% | -6.55M | |
| -$1.42-16.4% | -$1.22-19.6% | -$1.02-5.2% | -$0.97+1.0% | -$0.98+61.7% | ||
| EPS (basic) | -$1.42-16.4% | -$1.22-20.8% | -$1.01-9.8% | -$0.92-922.2% | -$0.09+96.5% | |
| Weighted-avg shares (basic) | 187M+18.3% | 158M+98.3% | 79.8M+3.8% | 76.9M+0.6% | 76.4M+25.7% | |
| Weighted-avg shares (diluted) | 187M+18.3% | 158M+84.9% | 85.6M+3.6% | 82.6M+0.6% | 82.2M+35.2% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 782M+77.4% | 441M+89.9% | 232M+79.2% | 130M-32.2% | 191M-22.3% | ||
| Cash & equivalents | 737M+88.0% | 392M+100.2% | 196M+91.4% | 102M-37.7% | 164M-28.0% | |
| Accounts receivable | 30.6M-5.4% | 32.4M+23.7% | 26.2M+22.8% | 21.3M+0.9% | 21.1M+72.5% | |
| Inventory | 3.56M+17.2% | 3.04M+31.9% | 2.31M+16.8% | 1.97M+57.9% | 1.25M+4.1% | |
| Prepaid expenses | 10.9M-19.3% | 13.5M+72.7% | 7.79M+93.5% | 4.03M-15.2% | 4.75M+2.2% | |
| 808M+76.5% | 458M+81.7% | 252M+68.8% | 149M-27.1% | 205M-21.8% | ||
| Property, plant & equipment | 19.7M+109.6% | 9.39M-20.0% | 11.7M+19.1% | 9.86M+41.7% | 6.96M-14.1% | |
| Operating lease right-of-use | 4.64M-22.0% | 5.95M-8.1% | 6.47M-19.5% | 8.04M+65.2% | 4.87M-16.7% | |
| 50.8M+22.9% | 41.4M+18.5% | 34.9M+11.2% | 31.4M+19.2% | 26.3M-1.2% | ||
| Accounts payable | 4.15M-0.5% | 4.18M-4.9% | 4.39M-14.3% | 5.12M+11.6% | 4.59M+69.5% | |
| Accrued liabilities | 43.8M+24.8% | 35.1M+22.5% | 28.7M+19.0% | 24.1M+19.8% | 20.1M+40.6% | |
| Deferred revenue | — | 128K-49.8% | 255K-55.7% | 576K | — | |
| Current lease liability | 2.82M+45.7% | 1.93M+21.9% | 1.59M-0.8% | 1.60M-1.5% | 1.62M+19.6% | |
| 154M+7.8% | 143M-11.4% | 161M+41.3% | 114M-2.5% | 117M-37.1% | ||
| Deferred revenue (non-current) | 14.0M+0.0% | 14.0M-1.0% | 14.1M+5.6% | 13.4M+3.0% | 13.0M+8.3% | |
| Non-current lease liability | 2.81M-47.3% | 5.34M-22.3% | 6.88M-20.7% | 8.68M+46.5% | 5.92M-21.5% | |
| Operating lease liability (total) | 5.63M-22.6% | 7.28M-14.0% | 8.46M-17.6% | 10.3M+36.2% | 7.55M-15.2% | |
| Other non-current liabilities | 887K+529.1% | 141K+30.6% | 108K+16.1% | 93.0K | — | |
| 654M+107.5% | 315M+246.0% | 91.1M+157.6% | 35.4M-59.8% | 88.0M+15.6% | ||
| Common stock | 22.0K+37.5% | 16.0K+33.3% | 12.0K+50.0% | 8.00K+0.0% | 8.00K+0.0% | |
| Additional paid-in capital | 1.81B+50.1% | 1.21B+53.0% | 789M+20.9% | 652M+2.9% | 634M+3.0% | |
| Retained earnings | -1.16B-29.8% | -891M-27.7% | -698M-13.1% | -617M-13.0% | -546M-1.2% | |
| Total liabilities & equity | 808M+76.5% | 458M+81.7% | 252M+68.8% | 149M-27.1% | 205M-21.8% | |
| Common shares issued | 216M+36.9% | 158M+37.2% | 115M+48.9% | 77.2M+0.6% | 76.7M+1.0% | |
| Common shares outstanding | 216M+36.9% | 158M+37.2% | 115M+48.9% | 77.2M+0.6% | 76.7M+1.0% | |
| Shares outstanding (cover) | 218M+36.9% | 159M+7.0% | 149M+91.8% | 77.5M+1.0% | 76.8M+0.9% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -205M-52.1% | -135M-91.8% | -70.2M-17.8% | -59.6M+9.1% | -65.5M-22.4% | ||
| Depreciation & amortization | 4.32M+14.2% | 3.79M+26.9% | 2.98M+41.4% | 2.11M-12.9% | 2.42M-12.7% | |
| Share-based compensation | 43.2M+30.4% | 33.1M+85.7% | 17.8M+5.1% | 17.0M+13.3% | 15.0M+98.9% | |
| Change in receivables | -1.74M-128.0% | 6.21M+27.9% | 4.85M+2454.7% | 190K-97.9% | 8.88M-8.5% | |
| Change in inventory | 524K-28.7% | 735K+122.1% | 331K-54.3% | 724K+1377.6% | 49.0K-80.2% | |
| Change in payables | -887K-178.9% | -318K-154.5% | 583K+193.9% | -621K-134.6% | 1.80M+497.3% | |
| -11.9M-822.4% | -1.29M+78.8% | -6.09M-63.8% | -3.71M-211.1% | -1.19M-42.0% | ||
| Capital expenditure | 12.0M+832.5% | 1.29M-78.8% | 6.09M+63.8% | 3.71M+211.1% | 1.19M+42.0% | |
| Free cash flow | -217M-59.5% | -136M-78.1% | -76.3M-20.5% | -63.3M+5.1% | -66.7M-22.7% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Proceeds from sale of PP&E | 130K | — | — | — | — | |
| 562M+69.1% | 332M+95.6% | 170M+11580.1% | 1.45M-49.0% | 2.85M-98.7% | ||
| Long-term debt issued | 0.00 | 0.00-100.0% | 82.5M | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00-100.0% | 26.1M | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00-100.0% | 117M | 0.00 | 0.00-100.0% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 345M+75.9% | 196M+109.8% | 93.5M+251.1% | -61.9M+3.2% | -63.9M-136.8% | |
| Interest paid | 9.03M-58.1% | 21.5M+294.1% | 5.46M+154.5% | 2.15M+11.1% | 1.93M-17.9% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 2.64B+94.6% | 1.36B+283.4% | 354M+63.7% | 216M-59.5% | 535M-66.0% | |
| P/S | 50.9×+138.7% | 21.3×+247.3% | 6.1×+41.0% | 4.4×-64.6% | 12.3×-86.4% | |
| P/B | 4.0×-6.2% | 4.3×-90.5% | 45.1×+863.6% | 4.7×-23.0% | 6.1×-70.6% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: OCUL’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all OCUL filings on SEC EDGAR → Not investment advice.